Clinical Trial Update: Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 study of reduced-intensity conditioning followed by donor stem cell transplant for high-risk acute lymphoblastic leukemia in complete remission. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Reduced-intensity donor stem cell transplant

Snippet

Sponsor: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium | Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission | Phase 2 | Status: COMPLETED